Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 30 Aug 2024 The case for a global therapeutics development coalition: Building a therapeutics pipeline for pandemic and endemic diseases PLOS Global Public Health
Scientific articles 21 Aug 2024 Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in Eastern Africa The Journal of Infectious Diseases
Scientific articles 15 Aug 2024 Paving the way for affordable and equitable liposomal amphotericin B access worldwide The Lancet Global Health
Scientific articles 15 Aug 2024 A guide for the generation of repositories of clinical samples for research on Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 15 Aug 2024 A standardized clinical database for research in Chagas disease: The NHEPACHA network PLOS Neglected Tropical Diseases
Scientific articles 8 Aug 2024 The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis Trends in Parasitology
Scientific articles 5 Aug 2024 How do we classify organ involvement in Chagas disease? A systematic review of organ involvement since 1909, highlighting the urgent need for a universal classification system in chronic Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 1 Aug 2024 Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Lancet Infectious Diseases
Scientific articles 15 Jul 2024 Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome Journal of Epidemiology and Global Health
Scientific articles 15 Jul 2024 Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements Wellcome Open Research
Scientific articles 2 Jul 2024 Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021 American Journal of Tropical Medicine and Hygiene
Scientific articles 20 Jun 2024 A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh PLOS Neglected Tropical Diseases
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Scientific articles 21 May 2024 Modular and divergent synthesis of 2,N3-disubstituted 4-quinazolinones facilitated by regioselective N-alkylation Organic and Biomolecular Chemistry
Scientific articles 20 May 2024 Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment Antimicrobial Agents and Chemotherapy
Scientific articles 16 May 2024 Chagas disease in the United States: a call for increased investment and collaborative research The Lancet Regional Health – Americas